Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFERis a five-year project funded by the European Commission’sInnovative Medicines Initiative (IMI) 2 programme to evaluate different ways of assessing clinical patient preferences. 


To learn more about PREFER and whose preferences we are collecting, you can watch the following video: 


To stay up to date with the latest videos from PREFER, you can subscribe to the YouTube channel here. If you want more information on the project, you can read ECPC’s role in the project here